Cold Spring Harbor Perspectives in Biology,
Journal Year:
2024,
Volume and Issue:
16(7), P. a041467 - a041467
Published: April 15, 2024
Over
the
years,
many
computational
methods
have
been
created
for
analysis
of
impact
single
amino
acid
substitutions
resulting
from
single-nucleotide
variants
in
genome
coding
regions.
Historically,
all
supervised
and
thus
limited
by
inadequate
sizes
experimentally
curated
data
sets
lack
a
standardized
definition
variant
effect.
The
emergence
unsupervised,
deep
learning
(DL)-based
raised
an
important
question:
Can
machines
learn
language
life
unannotated
protein
sequence
well
enough
to
identify
significant
errors
"sentences"?
Our
suggests
that
some
unsupervised
perform
as
or
better
than
existing
methods.
Unsupervised
are
also
faster
can,
thus,
be
useful
large-scale
evaluations.
For
other
methods,
however,
their
performance
varies
both
evaluation
metrics
type
effect
being
predicted.
We
note
method
is
still
lacking
on
less-studied,
nonhuman
proteins
where
hold
most
promise.
Genome Medicine,
Journal Year:
2022,
Volume and Issue:
14(1)
Published: Oct. 8, 2022
Multiple
computational
approaches
have
been
developed
to
improve
our
understanding
of
genetic
variants.
However,
their
ability
identify
rare
pathogenic
variants
from
benign
ones
is
still
lacking.
Using
context
annotations
and
deep
learning
methods,
we
present
pathogenicity
prediction
models,
MetaRNN
MetaRNN-indel,
help
prioritize
nonsynonymous
single
nucleotide
(nsSNVs)
non-frameshift
insertion/deletions
(nfINDELs).
We
use
independent
test
sets
demonstrate
that
these
new
models
outperform
state-of-the-art
competitors
achieve
a
more
interpretable
score
distribution.
Importantly,
scores
both
are
comparable,
enabling
easy
adoption
integrated
genotype-phenotype
association
analysis
methods.
All
pre-computed
nsSNV
available
at
http://www.liulab.science/MetaRNN
.
The
stand-alone
program
also
https://github.com/Chang-Li2019/MetaRNN
Scientific Data,
Journal Year:
2024,
Volume and Issue:
11(1)
Published: May 14, 2024
Abstract
Single
amino
acid
substitutions
can
profoundly
affect
protein
folding,
dynamics,
and
function.
The
ability
to
discern
between
benign
pathogenic
is
pivotal
for
therapeutic
interventions
research
directions.
Given
the
limitations
in
experimental
examination
of
these
variants,
AlphaMissense
has
emerged
as
a
promising
predictor
pathogenicity
missense
variants.
Since
heterogenous
performance
on
different
types
proteins
be
expected,
we
assessed
efficacy
across
several
groups
(e.g.
soluble,
transmembrane,
mitochondrial
proteins)
regions
intramembrane,
membrane
interacting,
high
confidence
AlphaFold
segments)
using
ClinVar
data
validation.
Our
comprehensive
evaluation
showed
that
delivers
outstanding
performance,
with
MCC
scores
predominantly
0.6
0.74.
We
observed
low
disordered
datasets
related
CFTR
ABC
protein.
However,
superior
was
shown
when
benchmarked
against
quality
CFTR2
database.
results
emphasizes
AlphaMissense’s
potential
pinpointing
functional
hot
spots,
its
likely
surpassing
benchmarks
calculated
from
ProteinGym
datasets.
Human Genetics,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 21, 2025
Abstract
Regular,
systematic,
and
independent
assessments
of
computational
tools
that
are
used
to
predict
the
pathogenicity
missense
variants
necessary
evaluate
their
clinical
research
utility
guide
future
improvements.
The
Critical
Assessment
Genome
Interpretation
(CAGI)
conducts
ongoing
Annotate-All-Missense
(Missense
Marathon)
challenge,
in
which
variant
effect
predictors
(also
called
impact
predictors)
evaluated
on
added
disease-relevant
databases
following
prediction
submission
deadline.
Here
we
assess
submitted
CAGI
6
commonly
genetics,
recently
developed
deep
learning
methods.
We
examine
performance
across
a
range
settings
relevant
for
applications,
focusing
different
subsets
evaluation
data
as
well
high-specificity
high-sensitivity
regimes.
Our
evaluations
reveal
notable
advances
current
methods
relative
older,
well-cited
field.
While
meta-predictors
tend
outperform
constituent
individual
predictors,
several
newer
perform
comparably
meta-predictors.
Predictor
varies
between
regimes,
highlighting
may
be
optimal
use
cases.
also
characterize
two
potential
sources
bias.
Predictors
incorporate
allele
frequency
predictive
feature
have
reduced
when
distinguishing
pathogenic
from
very
rare
benign
variants,
trained
labels
curated
often
inherit
gene-level
label
imbalances.
findings
help
illuminate
modern
identify
areas
development.
Genome Medicine,
Journal Year:
2021,
Volume and Issue:
13(1)
Published: Oct. 14, 2021
Clinical
interpretation
of
genetic
variants
in
the
context
patient's
phenotype
is
becoming
largest
component
cost
and
time
expenditure
for
genome-based
diagnosis
rare
diseases.
Artificial
intelligence
(AI)
holds
promise
to
greatly
simplify
speed
genome
by
integrating
predictive
methods
with
growing
knowledge
disease.
Here
we
assess
diagnostic
performance
Fabric
GEM,
a
new,
AI-based,
clinical
decision
support
tool
expediting
interpretation.We
benchmarked
GEM
retrospective
cohort
119
probands,
mostly
NICU
infants,
diagnosed
diseases,
who
received
whole-genome
or
whole-exome
sequencing
(WGS,
WES).
We
replicated
our
analyses
separate
60
cases
collected
from
five
academic
medical
centers.
For
comparison,
also
analyzed
these
current
state-of-the-art
variant
prioritization
tools.
Included
comparisons
were
trio,
duo,
singleton
cases.
Variants
underpinning
diagnoses
spanned
diverse
modes
inheritance
types,
including
structural
(SVs).
Patient
phenotypes
extracted
notes
two
means:
manually
using
an
automated
natural
language
processing
(CNLP)
tool.
Finally,
14
previously
unsolved
reanalyzed.GEM
ranked
over
90%
causal
genes
among
top
second
candidate
prioritized
review
median
3
per
case,
either
curated
CNLP-derived
descriptions.
Ranking
trios
duos
was
unchanged
when
as
singletons.
In
17
20
SVs,
identified
SVs
19/20
within
five,
irrespective
whether
SV
calls
provided
inferred
ab
initio
its
own
internal
detection
algorithm.
showed
similar
absence
parental
genotypes.
Analysis
resulted
novel
finding
one
candidates
ultimately
not
advanced
upon
manual
cases,
no
new
findings
10
cases.GEM
enabled
inclusive
all
types
through
nomination
very
short
list
disorders
final
reporting.
combination
deep
phenotyping
CNLP,
enables
substantial
automation
disease
diagnosis,
potentially
decreasing
case
review.
The American Journal of Human Genetics,
Journal Year:
2022,
Volume and Issue:
109(3), P. 457 - 470
Published: Feb. 3, 2022
We
used
a
machine
learning
approach
to
analyze
the
within-gene
distribution
of
missense
variants
observed
in
hereditary
conditions
and
cancer.
When
applied
840
genes
from
ClinVar
database,
this
detected
significant
non-random
pathogenic
benign
387
(46%)
172
(20%)
genes,
respectively,
revealing
that
variant
clustering
is
widespread
across
human
exome.
This
likely
occurs
as
consequence
mechanisms
shaping
pathogenicity
at
protein
level,
illustrated
by
overlap
some
clusters
with
known
functional
domains.
then
took
advantage
these
findings
develop
predictor,
MutScore,
integrates
qualitative
features
DNA
substitutions
new
additional
information
derived
positional
clustering.
Using
random
forest
approach,
MutScore
was
able
identify
mutations
very
high
accuracy,
outperforming
existing
predictive
tools,
especially
for
associated
autosomal-dominant
disease
Thus,
changes
an
important
previously
underappreciated
feature
exome,
which
can
be
harnessed
improve
prediction
disambiguation
uncertain
significance.
Human Genetics,
Journal Year:
2022,
Volume and Issue:
141(10), P. 1549 - 1577
Published: April 30, 2022
Estimating
the
effects
of
variants
found
in
disease
driver
genes
opens
door
to
personalized
therapeutic
opportunities.
Clinical
associations
and
laboratory
experiments
can
only
characterize
a
tiny
fraction
all
available
variants,
leaving
majority
as
unknown
significance
(VUS).
In
silico
methods
bridge
this
gap
by
providing
instant
estimates
on
large
scale,
most
often
based
numerous
genetic
differences
between
species.
Despite
concerns
that
these
may
lack
reliability
individual
subjects,
their
practical
applications
over
cohorts
suggest
they
are
already
helpful
have
role
play
genome
interpretation
when
used
at
proper
scale
context.
review,
we
aim
gain
insights
into
training
validation
variant
effect
predicting
illustrate
representative
types
experimental
clinical
applications.
Objective
performance
assessments
using
various
datasets
not
yet
published
indicate
strengths
limitations
each
method.
These
show
cautious
use
impact
predictors
is
essential
for
addressing
challenges.
ABSTRACT
Computational
predictors
of
genetic
variant
effect
have
advanced
rapidly
in
recent
years.
These
programs
provide
clinical
and
research
laboratories
with
a
rapid
scalable
method
to
assess
the
likely
impacts
novel
variants.
However,
it
can
be
difficult
know
what
extent
we
trust
their
results.
To
benchmark
performance,
are
often
tested
against
large
datasets
known
pathogenic
benign
benchmarking
data
may
overlap
used
train
some
supervised
predictors,
which
leads
re-use
or
circularity,
resulting
inflated
performance
estimates
for
those
predictors.
Furthermore,
new
usually
found
by
authors
superior
all
previous
suggests
degree
computational
bias
benchmarking.
Large-scale
functional
assays
as
deep
mutational
scans
one
possible
solution
this
problem,
providing
independent
measurements.
In
Review,
discuss
key
advances
predictor
methodology,
current
strategies
how
derived
from
overcome
issue
circularity.
We
also
ability
such
directly
predict
mutations
might
affect
future
need
Causal
loss-of-function
(LOF)
variants
for
Mendelian
and
severe
complex
diseases
are
enriched
in
'mutation
intolerant'
genes.
We
show
how
such
observations
can
be
interpreted
light
of
a
model
mutation-selection
balance
use
the
to
relate
pathogenic
consequences
LOF
mutations
at
present
their
evolutionary
fitness
effects.
To
this
end,
we
first
infer
posterior
distributions
costs
17,318
autosomal
679
X-linked
genes
from
exome
sequences
56,855
individuals.
Estimated
loss
gene
copy
typically
above
1%;
they
tend
largest
genes,
whether
or
not
have
Y
homolog,
followed
by
pseudoautosomal
region.
compare
inferred
effects
all
possible
de
novo
those
identified
individuals
diagnosed
with
one
six
severe,
developmental
disorders.
Probands
carry
an
excess
estimated
10%;
as
simulation,
when
sampled
population,
highly
deleterious
only
couple
generations
old.
Moreover,
proportion
carried
probands
reflects
typical
age
onset
disease.
The
study
design
also
has
discernible
influence:
greater
is
detected
pedigree
than
case-control
studies,
autism,
simplex
multiplex
families
female
versus
male
probands.
Thus,
anchoring
human
genetics
population
genetic
allows
us
learn
about
different
mapping
strategies
traits.